EUROPE BLOOD PLASMA MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • EUROPE BLOOD PLASMA MARKET FORECAST 2020-2028

EUROPE BLOOD PLASMA MARKET FORECAST 2020-2028

The Europe blood plasma market is set to record growth at a CAGR of 6.39% during the forecast period, 2020-2028. The increasing incidences for immunodeficiency diseases and hemophilia, along with technological advancements, are the factors deemed to fuel the growth of the market in the region. The analysis of the Europe blood plasma market involves the market assessment of Germany, France, Italy, the United Kingdom, Poland, Belgium, Russia, and the rest of Europe. The UK houses a considerable number of plasma collection centers and immunology centers.

EUROPE BLOOD PLASMA MARKET FORECAST 2020-2028

Europe Blood Plasma Market by Mode of Delivery (Infusion Solutions, Gels, Sprays, Biomedical Sealants) by Blood Type (Immunoglobulin, Albumin, Hyperimmunes, Coagulation Factor Concentrates, Other Plasma Fractionation Products) by Therapeutic Indication (Immunology, Oncology, Pulmonology, Rheumatology, Transplantation, Neurology, Hematology, Other Application) by Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand Disease (Vwd), Other Application)  by End User (Hospitals and Clinics, Research Laboratories, Academic Institutions) and by Geography.

Request free sample

The Europe blood plasma market is set to record growth at a CAGR of 6.39% during the forecast period, 2020-2028. The increasing incidences for immunodeficiency diseases and hemophilia, along with technological advancements, are the factors deemed to fuel the growth of the market in the region.

Europe Blood Plasma Market

To know more about this report, request a free sample copy.

The analysis of the Europe blood plasma market involves the market assessment of Germany, France, Italy, the United Kingdom, Poland, Belgium, Russia, and the rest of Europe. The UK houses a considerable number of plasma collection centers and immunology centers. The rising cases of immunodeficiency disease and symptomatic knee osteoarthritis are the factors impacting the growth of the market in the UK. The rate of knee replacements ranges between 1/1000 and 6/1000 in the local authority areas for people above the age of 45. France is considered to be a major contributor to the blood plasma market in Europe. The regional players are keeping track of blood plasma supply. The country makes use of RFID technology for ensuring the appropriate tracking of blood plasma fractionation, thereby resulting in easy traceability solutions for blood plasma suppliers. There is also an increasing prevalence of symptomatic knee osteoarthritis in the country. Belgium has one of the best healthcare systems in Europe. The country allocates a considerable amount of its annual GDP for healthcare. The country has been recording a significant number of aging-related diseases. Such factors are projected to drive the growth of the country.

Biotest AG is a developer and provider of biotechnological and biological pharmaceutical products. The company develops products for hematology, clinical immunology, emergence medicine, and intensive care. The company distributes its products through its partners in North America, Asia, South America, Europe, Africa, and the Middle East. The company has its headquarters in Dreieich, Hessen, Germany.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • PARENT MARKET ANALYSIS: BLOOD MARKET
    • MARKET DEFINITION
    •    KEY DRIVERS
      • WIDESPREAD ACCEPTANCE OF IMMUNOGLOBULIN-BASED THERAPIES
      • GROWING USAGE OF ALBUMIN IN OTHER THERAPEUTIC AREAS
      • GROWING GERIATRIC POPULATION IN EUROPE
      • SPREAD OF COVID-19 IN EUROPEAN REGION
      • INCREASE IN THE PATIENT POOL FOR HEMOPHILIA TREATMENT
      • GROWTH IN AWARENESS ABOUT BLOOD AND PLASMA DONATION
      • RISE IN OCCURRENCE OF SPORTS INJURIES
    •    KEY RESTRAINTS
      • HIGH COST OF BLOOD PLASMA TREATMENTS
      • INCREASING USAGE OF RECOMBINANT PLASMA PRODUCTS IN THERAPEUTIC TREATMENTS
      • ADVERSE REACTIONS ASSOCIATED WITH POST-TRANSFUSION
      • STRINGENT REGULATIONS
  1. KEY ANALYTICS
    • KEY INVESTMENT INSIGHTS
    •    PORTER’S FIVE FORCE ANALYSIS
      • BUYER POWER
      • SUPPLIER POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • PLASMA THERAPEUTICS REGULATION
    • MARKET TRENDS
    • CLINICAL GUIDELINES
  2. MARKET BY BLOOD PLASMA DERIVATIVES
    •    IMMUNOGLOBULIN
      • INTRAVENOUS IMMUNOGLOBULIN
      • SUBCUTANEOUS IMMUNOGLOBULIN
      • OTHER IMMUNOGLOBULIN TYPE
    • ALBUMIN
    • HYPERIMMUNE
    • COAGULATION FACTOR CONCENTRATES
    • OTHER PLASMA FRACTIONATION PRODUCTS
  3. MARKET BY THERAPEUTIC INDICATION
    • NEUROLOGY
    • IMMUNOLOGY
    • ONCOLOGY
    • TRANSPLANTATION
    • HEMATOLOGY
    • RHEUMATOLOGY
    • PULMONOLOGY
    • OTHER THERAPEUTIC INDICATION
  4. MARKET BY DISORDER
    • IMMUNODEFICIENCY DISEASES
    • HYPOGAMMAGLOBULINEMIA
    • HEMOPHILIA
    • VON WILLEBRAND DISEASE (VWD)
    • OTHER DISORDER
  5. MARKET BY END-USER
    • HOSPITALS AND CLINICS
    • RESEARCH LABORATORIES
    • ACADEMIC INSTITUTIONS
  6. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • ADMA BIOLOGICS
    • ARTHREX
    • BIO PRODUCTS LABORATORY
    • BAXTER INTERNATIONAL
    • BIOTEST AG
    • CERUS CORPORATION (CERUS)
    • CHINA BIOLOGIC PRODUCTS
    • CSL LIMITED
    • FUSION HEALTH CARE
    • GREEN CROSS HOLDINGS CORPORATION
    • GRIFOLS
    • LFB
    • OCTAPHARMA
    • TAKEDA PHARMACEUTICAL COMPANY
    • KEDRION BIOPHARMA INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BLOOD PLASMA

TABLE 2: EUROPE BLOOD PLASMA MARKET, BY BLOOD PLASMA DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: EUROPE BLOOD PLASMA MARKET, BY BLOOD PLASMA DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: EUROPE IMMUNOGLOBULIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: EUROPE IMMUNOGLOBULIN MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: EUROPE BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: EUROPE BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: EUROPE BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: EUROPE BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 10: EUROPE BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: EUROPE BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 12: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: EUROPE BLOOD PLASMA MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: KEY INVESTMENT INSIGHTS

FIGURE 2: PORTER’S FIVE FORCE ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: EUROPE BLOOD PLASMA MARKET, GROWTH POTENTIAL, BY BLOOD PLASMA DERIVATIVES, IN 2019

FIGURE 6: EUROPE BLOOD PLASMA MARKET, BY IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 7: EUROPE IMMUNOGLOBULIN MARKET, BY INTRAVENOUS IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 8: EUROPE IMMUNOGLOBULIN MARKET, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 9: EUROPE IMMUNOGLOBULIN MARKET, BY OTHER IMMUNOGLOBULIN TYPE, 2020-2028 (IN $ MILLION)

FIGURE 10: EUROPE BLOOD PLASMA MARKET, BY ALBUMIN, 2020-2028 (IN $ MILLION)

FIGURE 11: EUROPE BLOOD PLASMA MARKET, BY HYPERIMMUNE, 2020-2028 (IN $ MILLION)

FIGURE 12: EUROPE BLOOD PLASMA MARKET, BY COAGULATION FACTOR CONCENTRATES, 2020-2028 (IN $ MILLION)

FIGURE 13: EUROPE BLOOD PLASMA MARKET, BY OTHER PLASMA FRACTIONATION PRODUCTS, 2020-2028 (IN $ MILLION)

FIGURE 14: EUROPE BLOOD PLASMA MARKET, GROWTH POTENTIAL, BY THERAPEUTIC INDICATION, IN 2019

FIGURE 15: EUROPE BLOOD PLASMA MARKET, BY NEUROLOGY, 2020-2028 (IN $ MILLION)

FIGURE 16: EUROPE BLOOD PLASMA MARKET, BY IMMUNOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 17: EUROPE BLOOD PLASMA MARKET, BY ONCOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 18: EUROPE BLOOD PLASMA MARKET, BY TRANSPLANTATION, 2020-2028 (IN $ MILLION)

FIGURE 19: EUROPE BLOOD PLASMA MARKET, BY HEMATOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 20: EUROPE BLOOD PLASMA MARKET, BY RHEUMATOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 21: EUROPE BLOOD PLASMA MARKET, BY PULMONOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 22: EUROPE BLOOD PLASMA MARKET, BY OTHER THERAPEUTIC INDICATION, 2020-2028 (IN $ MILLION)

FIGURE 23: EUROPE BLOOD PLASMA MARKET, GROWTH POTENTIAL, BY DISORDER, IN 2019

FIGURE 24: EUROPE BLOOD PLASMA MARKET, BY IMMUNODEFICIENCY DISEASES, 2020-2028 (IN $ MILLION)

FIGURE 25: EUROPE BLOOD PLASMA MARKET, BY HYPOGAMMAGLOBULINEMIA, 2020-2028 (IN $ MILLION)

FIGURE 26: EUROPE BLOOD PLASMA MARKET, BY HEMOPHILIA, 2020-2028 (IN $ MILLION)

FIGURE 27: EUROPE BLOOD PLASMA MARKET, BY VON WILLEBRAND DISEASE (VWD), 2020-2028 (IN $ MILLION)

FIGURE 28: EUROPE BLOOD PLASMA MARKET, BY OTHER DISORDER, 2020-2028 (IN $ MILLION)

FIGURE 29: EUROPE BLOOD PLASMA MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019

FIGURE 30: EUROPE BLOOD PLASMA MARKET, BY HOSPITALS AND CLINICS, 2020-2028 (IN $ MILLION)

FIGURE 31: EUROPE BLOOD PLASMA MARKET, BY RESEARCH LABORATORIES, 2020-2028 (IN $ MILLION)

FIGURE 32: EUROPE BLOOD PLASMA MARKET, BY ACADEMIC INSTITUTIONS, 2020-2028 (IN $ MILLION)

FIGURE 33: EUROPE BLOOD PLASMA MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)

FIGURE 34: UNITED KINGDOM BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 35: GERMANY BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 36: FRANCE BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 37: ITALY BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 38: RUSSIA BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 39: BELGIUM BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 40: POLAND BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 41: REST OF EUROPE BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY BLOOD PLASMA DERIVATIVES
    •    IMMUNOGLOBULIN
      • INTRAVENOUS IMMUNOGLOBULIN
      • SUBCUTANEOUS IMMUNOGLOBULIN
      • OTHER IMMUNOGLOBULIN TYPE
    • ALBUMIN
    • HYPERIMMUNE
    • COAGULATION FACTOR CONCENTRATES
    • OTHER PLASMA FRACTIONATION PRODUCTS
  2. MARKET BY THERAPEUTIC INDICATION
    • NEUROLOGY
    • IMMUNOLOGY
    • ONCOLOGY
    • TRANSPLANTATION
    • HEMATOLOGY
    • RHEUMATOLOGY
    • PULMONOLOGY
    • OTHER THERAPEUTIC INDICATION
  3. MARKET BY DISORDER
    • IMMUNODEFICIENCY DISEASES
    • HYPOGAMMAGLOBULINEMIA
    • HEMOPHILIA
    • VON WILLEBRAND DISEASE (VWD)
    • OTHER DISORDER
  4. MARKET BY END-USER
    • HOSPITALS AND CLINICS
    • RESEARCH LABORATORIES
    • ACADEMIC INSTITUTIONS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now